Iodonium Ylide Mediated Radiofluorination of Aromatic Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge in radiochemistry is the difficulty in forming aromatic C-F bonds, particularly with the short-lived radionuclide fluorine-18, which is essential for positron emission tomography, especially for non-activated aromatic compounds that cannot be labeled using conventional nucleophilic substitution reactions.
Innovation Solution
A process involving the oxidation of aromatic iodide compounds to form iodonium compounds, which are then reacted with a specific compound to create iodonium ylides, followed by reaction with a fluoride source to produce aromatic fluoride compounds, utilizing a spirocyclic hypervalent iodine(III)-mediated strategy for radiofluorination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional nucleophilic substitution reactions are used for aromatic fluorination, then the reaction works well for activated aromatic compounds, but it fails for non-activated aromatic compounds
Solution Approach 1:
The patent introduces an iodonium ylide intermediate as a mediator in the fluorination reaction. The iodonium ylide (formed from aryl iodide and iodine(III) reagent) serves as a reactive intermediate that enables fluorine transfer to both activated and non-activated aromatic compounds, thereby extending the applicability beyond what conventional nucleophilic substitution can achieve.
Solution Approach 2:
The patent changes the reaction mechanism from direct nucleophilic substitution to a two-step process involving iodonium ylide formation and subsequent fluorine transfer. This parameter change in the reaction pathway enables the fluorination of non-activated aromatic compounds while maintaining reliability for activated compounds.
2Ease of manufacture
If electrophilic fluorination reactions with carrier-added 18F are used, then the reaction can proceed, but the specific activity is reduced due to isotope dilution
Solution Approach 1:
The patent extracts the fluorine source from carrier-added form to no-carrier-added 18F form. By using the iodonium ylide as a mediator, the reaction can proceed with high-specific-activity no-carrier-added 18F, eliminating the need for carrier fluorine that would dilute the specific activity, while still maintaining reaction feasibility.
Solution Approach 2:
The patent uses the iodonium ylide as a reactive intermediate that carries the 18F label. This intermediate acts as a 'copy' or vector that transfers the high-specific-activity 18F to the aromatic substrate without requiring carrier-added fluorine, thereby preserving specific activity while enabling the reaction to proceed.
3Adaptability or versatility
If short-lived radionuclide fluorine-18 is used for PET imaging, then the imaging applications are enabled, but the time window for synthesis and administration is limited
Solution Approach 1:
The patent employs a continuous multi-step reaction sequence where the iodonium ylide intermediate is formed in situ and immediately reacts with the fluoride source. This continuous process minimizes intermediate isolation and purification steps, reducing the overall synthesis time and maximizing the utilization of the short-lived 18F radionuclide.
Solution Approach 2:
The patent prepares the iodonium ylide intermediate as a stable precursor that can be stored and then reacted with no-carrier-added 18F when needed. This preliminary formation of the reactive intermediate allows for flexible timing and reduces the critical time window constraints by separating precursor preparation from the actual radiolabeling step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for high radiochemical yields and excellent regioselectivity, enabling the incorporation of fluorine-18 into a wide array of aromatic compounds, including non-activated ones, making it suitable for routine radiopharmaceutical production.
Implementation Method 1
reacting the iodonium ylide with a fluoride source to form an aromatic fluoride compound
Implementation Method 2
oxidizing an aromatic iodide compound (Ar-I), to form an iodonium compound
Data Source
Figure 1A~1B
Figure 2A
Figure 2B
AI summary
A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18F is described. Processes, intermediates, reagents and radiolabelled compounds are described.